Biofield Pharma Private Limited

AMALRAFT is a clinically trusted gastro-protective formulation containing Sodium Alginate 250 mg + Sodium Bicarbonate 138 mg + Calcium Carbonate 80 mg. It is widely prescribed for the effective management of acid reflux, heartburn, hyperacidity, and Gastroesophageal Reflux Disease (GERD).

With its advanced triple-action mechanism, AMALRAFT provides rapid and long-lasting relief by forming a protective barrier that prevents stomach acid from flowing back into the esophagus—helping patients experience improved digestive comfort and quality of life.

Manufactured in a WHO-GMP, USFDA, and EUGMP-certified facility, AMALRAFT ensures high purity, consistent quality, optimal stability, and excellent patient compliance, making it ideal for PCD Pharma Franchise, third-party manufacturing, and export markets.

• Sodium Alginate reacts with gastric acid to form a thick gel “raft” that floats on top of stomach contents, preventing acid reflux.

• Sodium Bicarbonate neutralizes excess acid and releases carbon dioxide, enabling the alginate raft to float effectively.

• Calcium Carbonate provides additional fast-acting and sustained acid neutralization.

This unique combination delivers immediate symptom relief and prolonged protection from acid irritation.

✅ Fast relief from heartburn and acidity
✅ Forms protective raft barrier against reflux
✅ Dual antacid action for quick & sustained comfort
✅ Effective in GERD & post-meal acidity
✅ Reduces burning sensation, regurgitation & sour taste
✅ Suitable for daytime & nighttime use
✅ Manufactured in WHO-GMP & USFDA-certified facilities
✅ EUGMP-compliant for regulated export markets
✅ PCD Pharma Franchise & third-party manufacturing ready
✅ Premium packaging for enhanced stability & shelf life

✔️ Gastroesophageal Reflux Disease (GERD)
✔️ Acid reflux & regurgitation
✔️ Heartburn
✔️ Hyperacidity
✔️ Acid-related indigestion

Dose: As prescribed by the physician

• Commonly taken after meals and at bedtime

• Administer as directed by healthcare professional

• Shake well before use (for suspension form)

• Mild bloating

• Nausea

• Constipation (rare)

• Excessive use may cause calcium-related effects

✅ DMF-grade raw materials for superior safety
✅ Clinically established gastro-protective ingredients
✅ Strict quality control & contamination prevention
✅ High stability formulation for extended shelf life
✅ Ideal for domestic and international markets

✔️ PCD Pharma Franchise for antacid & GERD medicines
✔️ Third-party manufacturing of Sodium Alginate combination
✔️ WHO-GMP certified antacid manufacturer
✔️ USFDA & EUGMP approved gastrointestinal products for export

Additional Information:

• Production Capacity: Fully automated, ISO & USFDA-compliant 600,000 Sq. ft. plant with zero liquid & gas discharge facility
• Delivery Time: 45-60 days
• Packaging Details: Our packaging is designed to ensure maximum product safety, stability, and market appeal. We utilize high-quality raw materials (RM) and USFDA-approved packaging components, making our products ideal for export and third-party manufacturing. Key Features of Our Packaging: ✅ Attractive & Market-Differentiating Designs: Our products come with customizable branding and change parts, allowing businesses to create a distinct identity in the pharma market. ✅ Pharmaceutical-Grade Materials: We use high-density PET bottles, tamper-evident caps, and premium blister foils to maintain product integrity. ✅ Advanced Protection: Our packaging is moisture-resistant, UV-protected, and oxidation-resistant, ensuring longer shelf life and stability. ✅ High-Precision Batch Coding & Labeling: We use laser batch coding, holographic labels, and serialized QR codes for authenticity and traceability. ✅ International Standards for Export: All our packaging materials meet USFDA, EUGMP, and WHO-GMP regulations, ensuring global compliance. Our packaging solutions help PCD Pharma companies, third-party manufacturers, and exporters differentiate their products in highly competitive markets while maintaining the highest pharmaceutical standards.

AMALRAFT is a clinically formulated antimalarial suspension designed to provide effective treatment for uncomplicated malaria in pediatric patients. Its fast-acting and reliable mechanism helps clear parasitic infection while supporting recovery and reducing fever and associated symptoms.

Manufactured in a WHO-GMP-certified facility under stringent quality control standards, AMALRAFT ensures high purity, accurate dosing, optimal stability, and enhanced pediatric compliance. It is ideally positioned for PCD Pharma Franchise, third-party manufacturing, and regulated export markets.

• Acts against Plasmodium parasites causing malaria

• Inhibits parasite growth and replication in red blood cells

• Rapidly reduces parasitic load to control infection

• Helps reduce fever and chills associated with malaria

• Supports improved hydration and overall comfort

• Promotes faster recovery in pediatric patients

• Clinically proven antimalarial therapy for children

• Rapid parasite clearance and symptomatic relief

• Supports recovery from fever and malaise

• Pediatric-friendly suspension with pleasant taste

• Accurate dropper or spoon dosing for precise administration

• WHO-GMP-certified manufacturing

• Leak-proof, stable packaging for extended shelf life

• Ideal for domestic and export markets

• PCD Pharma Franchise & third-party manufacturing ready

• Uncomplicated malaria in children

• Fever due to Plasmodium falciparum or Plasmodium vivax infection

• Pediatric patients requiring oral antimalarial therapy

• Dose: As directed by the physician

• Pediatric dosing based on age and body weight

• Shake well before use

• Use the provided calibrated spoon or dropper for accurate dosing

• Nausea or vomiting

• Mild gastrointestinal discomfort

• Temporary headache

• Rare hypersensitivity reactions

• Clinically established pediatric antimalarial therapy

• High-quality API and excipients for safety and efficacy

• Strict quality assurance and contamination control

• Pediatric-friendly suspension for easy administration

• Strong franchise and export potential

Ideal for partners seeking:

• Pediatric antimalarial suspension PCD Franchise

• Third-party manufacturing of antimalarial oral formulations

• WHO-GMP-certified pediatric manufacturer

• Export-ready malaria treatment products

Additional Information:

• Production Capacity: Fully automated, ISO & USFDA-compliant 600,000 Sq. ft. plant with zero liquid & gas discharge facility
• Delivery Time: 45-60 DAYS
• Packaging Details: Our packaging is designed to ensure maximum product safety, stability, and market appeal. We utilize high-quality raw materials (RM) and USFDA-approved packaging components, making our products ideal for export and third-party manufacturing. Key Features of Our Packaging: ✅ Attractive & Market-Differentiating Designs: Our products come with customizable branding and change parts, allowing businesses to create a distinct identity in the pharma market. ✅ Pharmaceutical-Grade Materials: We use high-density PET bottles, tamper-evident caps, and premium blister foils to maintain product integrity. ✅ Advanced Protection: Our packaging is moisture-resistant, UV-protected, and oxidation-resistant, ensuring longer shelf life and stability. ✅ High-Precision Batch Coding & Labeling: We use laser batch coding, holographic labels, and serialized QR codes for authenticity and traceability. ✅ International Standards for Export: All our packaging materials meet USFDA, EUGMP, and WHO-GMP regulations, ensuring global compliance. Our packaging solutions help PCD Pharma companies, third-party manufacturers, and exporters differentiate their products in highly competitive markets while maintaining the highest pharmaceutical standards.

ESINOM-20 is a clinically proven formulation of Esomeprazole Magnesium Trihydrate 20 mg, designed for effective management of acid-related gastrointestinal disorders. By inhibiting gastric acid secretion at the source, it provides rapid relief from heartburn, acid reflux, and related conditions while promoting healing of the gastric mucosa.

Manufactured in WHO-GMP certified facilities with strict quality control, ESINOM-20 ensures high purity, consistent potency, and optimal bioavailability. It is suitable for PCD Pharma Franchise, third-party manufacturing, and regulated export markets.

• Proton pump inhibitor (PPI) that blocks H+/K+ ATPase enzyme in stomach lining

• Reduces gastric acid secretion

• Increases gastric pH for symptom relief

• Promotes healing of esophageal and gastric mucosa

• Provides longer-lasting acid suppression compared to conventional antacids

✅ Rapid and effective relief from heartburn, acidity, and GERD
✅ Promotes healing of erosive esophagitis and gastric ulcers
✅ Provides longer-lasting acid control
✅ Once-daily dosing enhances patient compliance
✅ Suitable for chronic and intermittent use under medical supervision
✅ WHO-GMP certified manufacturing for superior quality
✅ Ideal for PCD Pharma Franchise & third-party manufacturing

✔️ Gastroesophageal reflux disease (GERD)
✔️ Heartburn and acid regurgitation
✔️ Erosive esophagitis
✔️ Zollinger-Ellison syndrome (as prescribed)
✔️ Gastric and duodenal ulcers
✔️ Prevention of NSAID-induced gastric irritation

Dose: As directed by the physician

• Usually 20 mg once daily, preferably 30–60 minutes before a meal

• Swallow whole; do not crush or chew

• Duration of therapy depends on condition severity and physician’s advice

ESINOM-20 is generally well tolerated.

Common Mild Side Effects:

• Headache

• Nausea

• Mild diarrhea or constipation

• Abdominal discomfort

Rare Effects:

• Vitamin B12 deficiency with long-term use

• Hypomagnesemia (low magnesium levels)

Patients should use under medical supervision, especially during long-term therapy.

✅ High-quality, WHO-GMP certified API
✅ Clinically proven PPI for effective acid suppression
✅ Reliable therapeutic performance
✅ Strong market demand for acid-related disorders
✅ Suitable for franchise, third-party manufacturing, and export markets

✔️ PCD Pharma Franchise for gastro-protective medicines
✔️ Third-party manufacturing of PPIs
✔️ WHO-GMP certified gastrointestinal product manufacturer
✔️ Export-ready acid-suppressive formulations

Additional Information:

• Production Capacity: Fully automated, ISO & USFDA-compliant 600,000 Sq. ft. plant with zero liquid & gas discharge facility
• Delivery Time: 45-60 DAYS
• Packaging Details: Our packaging is designed to ensure maximum product safety, stability, and market appeal. We utilize high-quality raw materials (RM) and USFDA-approved packaging components, making our products ideal for export and third-party manufacturing. Key Features of Our Packaging: ✅ Attractive & Market-Differentiating Designs: Our products come with customizable branding and change parts, allowing businesses to create a distinct identity in the pharma market. ✅ Pharmaceutical-Grade Materials: We use high-density PET bottles, tamper-evident caps, and premium blister foils to maintain product integrity. ✅ Advanced Protection: Our packaging is moisture-resistant, UV-protected, and oxidation-resistant, ensuring longer shelf life and stability. ✅ High-Precision Batch Coding & Labeling: We use laser batch coding, holographic labels, and serialized QR codes for authenticity and traceability. ✅ International Standards for Export: All our packaging materials meet USFDA, EUGMP, and WHO-GMP regulations, ensuring global compliance. Our packaging solutions help PCD Pharma companies, third-party manufacturers, and exporters differentiate their products in highly competitive markets while maintaining the highest pharmaceutical standards.

PEPTERM is a clinically formulated digestive enzyme suspension designed to support optimal digestion and nutrient absorption in both children and adults. Its multi-enzyme action helps reduce bloating, indigestion, and discomfort after meals while promoting overall gastrointestinal health.

Manufactured in a WHO-GMP-certified facility under stringent quality control standards, PEPTERM ensures high purity, stable enzyme activity, precise dosing, and enhanced patient compliance. It is ideally positioned for PCD Pharma Franchise, third-party manufacturing, and regulated export markets.

• Provides essential enzymes (e.g., protease, amylase, lipase) to aid in breaking down proteins, carbohydrates, and fats

• Enhances digestion and nutrient absorption

• Reduces post-meal bloating, heaviness, and discomfort

• Supports normal gut motility and reduces flatulence

• Helps in cases of enzyme deficiency, indigestion, or pancreatic insufficiency

• Promotes overall digestive wellness

• Improves nutrient uptake from food

• Supports energy metabolism and overall health

• Beneficial for both pediatric and adult patients

• Clinically effective digestive enzyme formulation

• Supports proper digestion of proteins, fats, and carbohydrates

• Reduces bloating, gas, and post-meal discomfort

• Suitable for pediatric and adult use

• Accurate dosing with measuring spoon or dropper

• Pleasant taste for better acceptance in children

• WHO-GMP-certified manufacturing

• Stable, leak-proof packaging for extended shelf life

• Ideal for domestic and export markets

• PCD Pharma Franchise & third-party manufacturing ready

• Indigestion and bloating

• Enzyme deficiency or pancreatic insufficiency

• Flatulence and digestive discomfort

• Malabsorption syndromes

• Post-meal heaviness or discomfort

• Dose: As directed by the physician

• Pediatric and adult dosing based on age, weight, and clinical condition

• Shake well before use

• Use the provided measuring spoon or dropper for accurate dosing

• Mild gastrointestinal discomfort

• Nausea (rare)

• Occasional loose stools

• Rare allergic reactions

• Scientifically formulated multi-enzyme suspension

• High-quality API and excipients for safety and efficacy

• Strict quality assurance and contamination control

• Pediatric-friendly taste and adult-friendly dosing

• Supports overall digestive health and nutrient absorption

• Strong franchise and export potential

Ideal for partners seeking:

• Pediatric and adult digestive enzyme suspension PCD Franchise

• Third-party manufacturing of enzyme-based digestive supplements

• WHO-GMP-certified gastrointestinal care manufacturer

• Export-ready digestive health products

Additional Information:

• Production Capacity: Fully automated, ISO & USFDA-compliant 600,000 Sq. ft. plant with zero liquid & gas discharge facility
• Delivery Time: 45-60 days
• Packaging Details: Our packaging is designed to ensure maximum product safety, stability, and market appeal. We utilize high-quality raw materials (RM) and USFDA-approved packaging components, making our products ideal for export and third-party manufacturing. Key Features of Our Packaging: ✅ Attractive & Market-Differentiating Designs: Our products come with customizable branding and change parts, allowing businesses to create a distinct identity in the pharma market. ✅ Pharmaceutical-Grade Materials: We use high-density PET bottles, tamper-evident caps, and premium blister foils to maintain product integrity. ✅ Advanced Protection: Our packaging is moisture-resistant, UV-protected, and oxidation-resistant, ensuring longer shelf life and stability. ✅ High-Precision Batch Coding & Labeling: We use laser batch coding, holographic labels, and serialized QR codes for authenticity and traceability. ✅ International Standards for Export: All our packaging materials meet USFDA, EUGMP, and WHO-GMP regulations, ensuring global compliance. Our packaging solutions help PCD Pharma companies, third-party manufacturers, and exporters differentiate their products in highly competitive markets while maintaining the highest pharmaceutical standards.